1. Combination therapies utilizing neoepitope-targeted vaccines

   • Karin L. Lee
   • Jeffrey Schlom
   • Duane H. Hamilton

   Review Open access 08 October 2020 Pages: 875 - 885

   

2. Are all cytokine storms the same?

   • Nicki Panoskaltsis

   Commentary 08 January 2021 Pages: 887 - 892

   

3. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma

   • Katharina Leuchte
   • Elena Staib
   • Hans Anton Schlößer

   Original Article Open access 02 October 2020 Pages: 893 - 907

   

4. Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8⁺ T cells to enhance antitumor immunity

   • Rosmely Hernandez
   • Kevin H. Toomer
   • Thomas R. Malek

   Original Article 10 October 2020 Pages: 909 - 921

   

5. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment

   • Zuzana Saidak
   • Simon Soudet
   • Antoine Galmiche

   Original Article 15 October 2020 Pages: 923 - 933

   

6. Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review

   • Aasir M. Suliman
   • Shaza A. Bek
   • Nabil E. Omar

   Original Article Open access 17 October 2020 Pages: 935 - 944

   

7. Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial

   • Hiroto Matsui Matsui
   • Shoichi Hazama
   • Hiroaki Nagano

   Original Article 19 October 2020 Pages: 945 - 957

   

8. Correction to: Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial

   • Hiroto Matsui
   • Shoichi Hazama
   • Hiroaki Nagano

   Correction 05 January 2021 Pages: 959 - 959

9. Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)

   • Yeseul Kim
   • Elena Vagia
   • Young Kwang Chae

   Original Article 21 October 2020 Pages: 961 - 965

   

10. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma

    • Yifei Dai
    • Weijie Qiang
    • Dong Wang

    Original Article 21 October 2020 Pages: 967 - 979

    

11. Notch signaling defects in NK cells in patients with cancer

    • Gulnur K. Zakiryanova
    • Elena Kustova
    • Michael R. Shurin

    Original Article 21 October 2020 Pages: 981 - 988

    

12. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide

    • Ayman J. Oweida
    • Adam C. Mueller
    • Sana D. Karam

    Original Article 23 October 2020 Pages: 989 - 1000

    

13. Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers

    • Wei Zhang
    • Junping Shi
    • QiangLi

    Original Article 23 October 2020 Pages: 1001 - 1014

    

14. OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway

    • Xin Pang
    • Sha-sha Wang
    • Ya-ling Tang

    Original Article 26 October 2020 Pages: 1015 - 1029

    

15. Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts’ recommendations

    • Rodrigo Ramella Munhoz
    • Federico Cayol
    • Gabriela Cinat

    Original Article 26 October 2020 Pages: 1031 - 1036

    

16. Retinoblastoma cell-derived Twist protein promotes regulatory T cell development

    • Ruishi Zhang
    • Yan-Nan Song
    • Guohui Nie

    Original Article 27 October 2020 Pages: 1037 - 1048

    

17. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

    • Shiwen Peng
    • Marietta Tan
    • T.-C. Wu

    Original Article 27 October 2020 Pages: 1049 - 1062

    

18. Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer

    • Koji Teramoto
    • Tomoyuki Igarashi
    • Yataro Daigo

    Original Article 28 October 2020 Pages: 1063 - 1074

    

19. Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors

    • Gun-Young Jang
    • Young Seob Kim
    • Yeong-Min Park

    Original Article 28 October 2020 Pages: 1075 - 1088

    

20. Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

    • Johanna Winter
    • Max M. Lenders
    • Nikolaus B. Wagner

    Original Article 28 October 2020 Pages: 1089 - 1099

    

21. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

    • Simone Punt
    • Shruti Malu
    • Patrick Hwu

    Original Article Open access 29 October 2020 Pages: 1101 - 1113

    

22. Reduction of derived neutrophil-to-lymphocyte ratio after four weeks predicts the outcome of patients receiving second-line chemotherapy for metastatic colorectal cancer

    • Giuseppe Antonio Colloca
    • Antonella Venturino
    • Domenico Guarneri

    Original Article 29 October 2020 Pages: 1115 - 1125

    

23. Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm

    • Nicki Panoskaltsis
    • Neil E. McCarthy
    • Stella C. Knight

    Original Article 08 October 2020 Pages: 1127 - 1142

    

24. Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells

    • Neil E. McCarthy
    • Andrew J. Stagg
    • Nicki Panoskaltsis

    Original Article 13 October 2020 Pages: 1143 - 1153

    

25. Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm

    • Nicki Panoskaltsis
    • Neil E. McCarthy
    • Stella C. Knight

    Research Report 30 August 2020 Pages: 1155 - 1160

    

26. Selective CD47 targeting with a bispecific antibody

    • Walter Ferlin
    • Krzysztof Masternak
    • Limin Shang

    Letter to the Editors 02 January 2021 Pages: 1161 - 1162

    

27. Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy

    • Lukas Marcelis
    • Asier Antoranz
    • Thomas Tousseyn

    Correction 17 February 2021 Pages: 1163 - 1163